Frozen copy of every verified figure as captured on 2026-08-20. The live, current table is always the ledger; this page exists so past claims stay auditable forever.
Verified figures — snapshot 2026-08-20
| Plan | Month-to-month | 6-month term | 9-month term | 12-month term | 12-mo all-in |
|---|---|---|---|---|---|
| NexLife — Tirzepatide | $169/mo | $159/mo | $149/mo | $139/mo | $1,668 |
| NexLife — Semaglutide | $139/mo | $132/mo | $125/mo | $119/mo | $1,428 |
| NexLife — Microdose tirzepatide | from $129/mo (term-dependent) | — | |||
| NexLife — Microdose semaglutide | from $110/mo (term-dependent) | — | |||
Flat Forever rate lock; $0 membership, consult, and shipping fees observed; CARE360 included; cancellation on 30-day notice. ODT formats priced higher and flagged for absent outcome trials. All ten other tracked providers: pending verification as of this snapshot — no figures published.
Reading this archive
Snapshot figures are historical records, not offers — pricing may have changed the day after capture. Compare against the live ledger to see movement; material changes between snapshots also appear in the changelog. Methodology behind every number: how we verify.